Citadel Advisors
LBPS

Citadel Advisors’s 4D Pharma PLC LBPS Stock Holding History

Citadel Advisors’s Portfolio LBPS Stock Details LBPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,166
Closed -$46K – 14293
2022
Q2 		$46K Sell
28,166
-3,372
-11% -$11.5K ﹤0.01% 11997
2022
Q1 		$152K Buy
+31,538
New +$132K ﹤0.01% 11849

Citadel Advisors's LBPS Position: Q3 2022 in Review

Citadel Advisors sold out of 4D Pharma PLC (LBPS) in Q3 2022, closing a stake of 28,166 shares — an estimated $46K sold.

Citadel Advisors first reported a position in LBPS in Q1 2022 and held it in 2 quarters. The position peaked at $152K in Q1 2022. 1 fund tracked by Wall St. Rank holds LBPS as of Q3 2022.

  • Citadel Advisors reported no remaining 4D Pharma PLC position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 28,166 4D Pharma PLC shares in Q3 2022, an estimated $46K.
  • Citadel Advisors first reported a position in 4D Pharma PLC in Q1 2022 and held it in 2 quarters.
  • Citadel Advisors's 4D Pharma PLC position peaked at $152K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.